By suppressing signaling through the transforming growth factor-beta 1 and Smad3 pathway, elevated expression of MARK3 attenuated cellular damage, oxidative stress, and fibrotic trans-differentiation. The study, published in the Journal of Cardiothoracic Surgery, evaluated transcriptomic datasets alongside primary cell models to uncover the molecular mechanisms linking the ubiquitin system to cardiac remodeling.
To address this knowledge gap, the investigators sought to identify candidate ubiquitination-related genes that regulate disease development and could serve as diagnostic or therapeutic targets.
The researchers established their bioinformatic discovery pipeline by obtaining public bulk RNA-sequencing datasets, accessioned under GSE141910 and GSE116250, alongside a single-cell RNA-sequencing dataset cataloged as GSE222144 from the Gene Expression Omnibus repository. They combined differential gene expression analysis, weighted gene co-expression network analysis, and defined ubiquitination-related gene sets to isolate an initial panel of candidate genes. Downstream computational evaluations also encompassed immune cell infiltration characterization via CIBERSORTx, competing endogenous RNA networks, and transcription factor regulatory network mapping.
From the integrated screening, twenty ubiquitination-related candidate genes were initially identified. Machine learning algorithms subsequently narrowed this pool down to four core genes: CADPS2, DTX4, USP51, and MARK3. Using these identified markers, the authors constructed a predictive nomogram model that demonstrated strong diagnostic accuracy, yielding an area under the receiver operating characteristic curve exceeding 0.7. Single-cell RNA sequencing further demonstrated that cardiac fibroblasts serve as the primary cell population expressing these four key genes and exhibit intensified intercellular communication networks in heart failure tissue.
To investigate potential causal relationships with disease susceptibility, the authors performed Mendelian randomization analyses using genetic instruments. The resulting estimates indicated that genetically predicted lower expression levels of CADPS2 and MARK3, alongside higher expression of DTX4, were associated with an increased risk of developing heart failure. Meanwhile, the Mendelian randomization estimate for USP51 aligned directionally with these patterns but did not achieve formal statistical significance, highlighting distinct levels of genetic evidence across the candidate markers.
To experimentally validate these computational predictions, primary neonatal mouse cardiac fibroblasts were isolated and exposed in vitro to 10 micromolar isoproterenol for 24 hours to simulate heart failure stress. The pharmacological challenge significantly diminished cell viability in CCK-8 assays, elevated reactive oxygen species production, and increased the expression of the inflammatory cytokines TNF-alpha and interleukin-1 beta. Isoproterenol treatment also induced robust fibrotic markers, upregulating alpha-smooth muscle actin and Collagen I at the transcript and protein levels, while reproducing the bioinformatic expression profile by downregulating CADPS2 and MARK3 and upregulating DTX4 and USP51.
The functional role of MARK3 was directly verified by transfecting cultured fibroblasts with a pcDNA3.1-MARK3 overexpression plasmid.
Subject of Research: Identification and experimental validation of MARK3 and ubiquitination-related regulators in cardiac fibroblast activation during heart failure
Article Title: Integrative multi-omics analysis and experimental validation identify MARK3 as a key ubiquitination-related regulator of cardiac fibroblast activation in heart failure via the TGF-β1/Smad3 pathway
Article References: Xu, F., Zhang, J., Yu, Z., Tan, H., Zhang, S., Zou, X., Wu, S., & Gong, Y. (2026). Integrative multi-omics analysis and experimental validation identify MARK3 as a key ubiquitination-related regulator of cardiac fibroblast activation in heart failure via the TGF-β1/Smad3 pathway. Journal of Cardiothoracic Surgery. https://doi.org/10.1186/s13019-026-04695-5
Image Credits: AI Generated
DOI: 10.1186/s13019-026-04695-5
Keywords: Heart Failure, MARK3, Cardiac Fibroblasts, Ubiquitination, TGF-β1/Smad3 Pathway, Fibrosis, CADPS2, DTX4, USP51, Bulk RNA-seq, scRNA-seq, Mendelian Randomization, Isoproterenol, Reactive Oxygen Species, Inflammatory Cytokines, Neonatal Mouse Cardiac Fibroblasts
News Source: Ophelia Keating. (November 20, 2026). Study Identifies MARK3 as Key Regulator Limiting Fibrosis in Heart Failure. Scienmag.



